Logo del repository
  1. Home
 
Opzioni

FOUR PRIMARY MALIGNANCIES SUCCESSIVELY OCCURRED IN A BRCA2 MUTATION CARRIER: A CASE REPORT

FRUSCALZO, Arrigo
•
DAMANTE, Giuseppe
•
CALCAGNO, Angelo
altro
MARCHESONI, Diego
2006
  • journal article

Periodico
CANCER INVESTIGATION
Abstract
Carriers of BRCA2 germline mutation have a significantly increased lifetime risk of breast and ovarian cancer compared to non carriers. Several other carcinomas seem to be associated with BRCA2 mutations: pancreas, prostate, larynx, gallbladder, bile duct cancer, and malignant melanoma. We described a case of a 67-year-old BRCA2 mutation carrier of Caucasian, non-Jewish, ethnic origin who successively developed 4 primary malignancies in 30 months: breast ductal carcinoma, chronic lymphatic leukemia, ovarian serous papillary carcinoma, and endocervical adenocarcinoma. This is the first case of 4 primary malignancies in a BRCA mutation carrier, also occurred in such a short observation period. Chronic lymphatic leukemia and endocervical adenocarcinoma have not been yet associated to BRCA2 germline mutation.
DOI
10.1080/07357900600894872
WOS
WOS:000240594000009
Archivio
http://hdl.handle.net/11390/877025
info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-33748863624
Diritti
metadata only access
Scopus© citazioni
4
Data di acquisizione
Jun 15, 2022
Vedi dettagli
Web of Science© citazioni
7
Data di acquisizione
Mar 26, 2024
Visualizzazioni
2
Data di acquisizione
Apr 19, 2024
Vedi dettagli
google-scholar
Get Involved!
  • Source Code
  • Documentation
  • Slack Channel
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your nstitution's web identity.

Need professional help?

The original creators of DSpace-CRIS at 4Science can take your project to the next level, get in touch!

Realizzato con Software DSpace-CRIS - Estensione mantenuta e ottimizzata da 4Science

  • Impostazioni dei cookie
  • Informativa sulla privacy
  • Accordo con l'utente finale
  • Invia il tuo Feedback